Zentalis Pharmaceuticals announced the appointment of David Johnson to its Board of Directors. Mr. Johnson is a veteran biopharmaceutical and healthcare leader with more than 25 years of experience in developing drugs and growing companies. Mr. Johnson is currently the Chief Executive Officer at VelosBio. Prior to VelosBio, he was CEO at Acerta Pharma.